Ocrevus 300 MG/10 ML vial 10ML
Ended Awarded
- Contract number
- SPE2DR26FG1AF
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $101,332
Award facts
- Contract value 100% obligated
- $101,331.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $101,331.84 firm fixed-price delivery order to AmerisourceBergen Drug Corp for OCREVUS 300 mg/10 mL vials. This award, issued on November 13, 2025, with an ultimate completion date of December 5, 2025, is a non-set-aside contract supporting federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for military and veteran healthcare systems through the DLA's medical supply chain.
This delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and running through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical supplies to support military healthcare programs worldwide. OCREVUS, a specialty pharmaceutical treatment, aligns with AmerisourceBergen Drug Corp's established portfolio of specialty medications and brand-name drugs delivered through its extensive federal contract awards demonstrating competitive capability across the Defense Logistics Agency's medical procurement requirements.
Quick answers
Who was awarded contract SPE2DR26FG1AF?
SPE2DR26FG1AF was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 13, 2025.
How much is contract SPE2DR26FG1AF worth?
The government has obligated $101,332 on SPE2DR26FG1AF.
Is contract SPE2DR26FG1AF an order under another contract?
Yes. SPE2DR26FG1AF is a delivery order under SPE2DR25D3016, an indefinite delivery contract.
Was contract SPE2DR26FG1AF competed?
The extent of competition for SPE2DR26FG1AF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award